EURKU
Eureka Acquisition Corp
$11.50
-10.78%
No data for this timeframe.
Vol
SEC Reports5
Exchange Nasdaq·Sector Services-Computer Integrated Systems Design·Inc. E9·CIK 0002000410·Prev Close $12.89
Recent Activity
May 6, 2026
SEC
Eureka Acquisition Corp (EURKU) filed an 8-K as a Rule 425 communication to report a one-month extension of its deadline
425 — Impact 3/10
May 6, 2026
SEC
Eureka Acquisition Corp (EURKU) filed an 8-K to report its one-month extension of the deadline to consummate a business
8-K — Impact 3/10
Apr 8, 2026
SEC
Eureka Acquisition Corp issued a $150,000 unsecured promissory note to Marine Thinking Inc. to extend its deadline for c
425 — Impact 5/10
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 4 neutral. Avg impact: 4.8/10.
NEUTRAL
425
3/10
Eureka Acquisition Corp (EURKU) filed an 8-K as a Rule 425 communication to report a one-month exten
May 6, 2026
NEUTRAL
8-K
3/10
Eureka Acquisition Corp (EURKU) filed an 8-K to report its one-month extension of the deadline to co
May 6, 2026
NEUTRAL
425
5/10
Eureka Acquisition Corp issued a $150,000 unsecured promissory note to Marine Thinking Inc. to exten
Apr 8, 2026
NEUTRAL
8-K
5/10
Eureka Acquisition Corp issued a $150,000 unsecured promissory note to Marine Thinking Inc. to exten
Apr 8, 2026
BEARISH
8-K
8/10
Eureka Acquisition Corp (EURKU) received a delisting notice from Nasdaq for failing to maintain the
Apr 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.